Success Metrics

Completion Rate

0%(0/2)

Active Trials

0(0%)

Terminated

2(100%)

Phase Distribution

Ph phase_1

50%

Ph early_phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Early Phase 1First-in-human

1(50.0%)

Phase 1Safety & dosage

1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Terminated(2)

Detailed Status

Terminated2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 1

Trials by Phase

Early Phase 11 (50.0%)

Phase 11 (50.0%)

Trials by Status

terminated2100%

Recent Activity

0 active trials

Showing 2 of 2

terminatedearly_phase_1

Screening Inhaled Allergen Challenge for Dermatophagoides Farinae

NCT03049111

terminatedphase_1

Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.

NCT03023397

Clinical Trials (2)

Showing 2 of 2 trials

NCT03049111Early Phase 1

Screening Inhaled Allergen Challenge for Dermatophagoides Farinae

Terminated

NCT03023397Phase 1

Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.

Terminated

All 2 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 2